<< Back To Search

Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
Doctors conducted a small study to see if patients with a type of cancer called multiple myeloma who had received a specific type of treatment called autologous stem cell transplant and had no remaining cancer cells could safely stop taking medicine to prevent their cancer from coming back.
*Third Opinion AI Generated Synopsis

Trial Summary
A pilot study to assess the risk of progression after stopping post-autologous stem cell transplant (ASCT) maintenance therapy in Minimal Residual Disease (MRD)-negative MM patients.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Is There Anything Else You Would Like To Share?